Common stock closed stock public offering
Derma Sciences, Inc (Princeton, NJ) closed an underwritten public offering of 3,521,300 shares of common stock at a price to the public of $10.34 per share, which includes the exercise of the underwriters’ option to purchase 459,300 shares of common stock to cover over-allotments.
Total net proceeds to the company were approximately $33.8 million after deducting the underwriting discount and estimated offering expenses. The company plans to use these proceeds for the continued development of its drug candidate DSC127 for the treatment of diabetic foot ulcers and for general corporate purposes.
For more information, visit www.dermasciences.com. ... continue reading about New Products and Industry News